Evidence map›Paper›PMID 26401487›Full record

ArticleMeta gene2015

Mutational analysis of SCN5A gene in long QT syndrome.

Sameera Fatima Qureshi, Altaf Ali, Princy John, Amol P Jadhav, Ananthapur Venkateshwari, Hygriv Rao, M P Jayakrishnan, Calambur Narasimhan, Jayaprakash Shenthar, Kumarasamy Thangaraj and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Meta gene, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. International journal of molecular sciences · 2022
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 1 country.

Sameera Fatima QureshiDept. of Genetics, University College of Science, Osmania University, Hyderabad 500007, Andhra Pradesh, India.
Altaf AliDept. of Genetics, University College of Science, Osmania University, Hyderabad 500007, Andhra Pradesh, India.
Princy JohnDept. of Genetics, University College of Science, Osmania University, Hyderabad 500007, Andhra Pradesh, India.
Amol P JadhavDept. of Genetics, University College of Science, Osmania University, Hyderabad 500007, Andhra Pradesh, India.
Ananthapur VenkateshwariInstitute of Genetics and Hospital for Genetic Diseases, Osmania University, Begumpet, Hyderabad 500016, Andhra Pradesh, India.
Hygriv RaoKrishna Institute of Medical Sciences, 1-8-31/1, Minister Road, Secunderabad 500 003, Andhra Pradesh, India.
M P JayakrishnanInstitute of Maternal and Child Health, Calicut Medical College, Calicut 8, Kerala, India.
Calambur NarasimhanCare Hospital, Hyderabad, Andhra Pradesh, India.
Jayaprakash ShentharSri Jayadeva Institute of Cardiovascular Science and Research, Jayanagar 9th Block, Bannerghatta Road, Bangalore 560069, Karnataka, India.
Kumarasamy ThangarajCentre for Cellular and Molecular Biology, Uppal Road, Hyderabad 500 007, Andhra Pradesh, India.
Pratibha NallariDept. of Genetics, University College of Science, Osmania University, Hyderabad 500007, Andhra Pradesh, India.
Osmania University · INCARE Hospitals · INCentre for Cellular and Molecular Biology · INGovernment Medical College · INInstitute of Genetics and Hospital for Genetic Diseases · INKrishna Institute of Medical Sciences · INSri Jayadeva Institute of Cardiovascular Sciences and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SCN5A gene encodes for the INa channel implicated in long QT syndrome type-3 (LQTS-type-3). Clinical symptoms of this type are lethal as most patients had a sudden death during sleep. Screening of SCN5A in South Indian cohort by PCR-SSCP analyses revealed five polymorphisms - A29A (exon-2), H558R (exon-12), E1061E and S1074R (exon-17) and IVS25 + 65G > A (exon-25) respectively. In-silico and statistical analyses were performed on all the polymorphisms. Exon-2 of SCN5A gene revealed A282G polymorphism (rs6599230), resulting in alanine for alanine (A29A) silent substitution in the N-terminus of SCN5A protein. Exon-12 showed A1868G polymorphism (H558R - rs1805124) and its 'AA' genotype and 'A' allele frequency were found to be higher in LQTS patients pointing towards its role in LQTS etiology. Two polymorphisms A3378G (E1061E) and the novel C3417A (S1074R) were identified as compound heterozygotes/genetic compounds in exon-17 of SCN5A located in the DIIS6-DIIIS1 domain of the SCN5A transmembrane protein. IVS25 + 65G > A was identified in intron-25 of SCN5A. The 'G' allele was identified as the risk allele. Variations were identified in in-silico analyses which revealed that these genetic compounds may lead to downstream signaling variations causing aberrations in sodium channel functions leading to prolonged QTc. The compound heterozygotes of SCN5A gene polymorphisms revealed a significant association which may be deleterious/lethal leading to an aberrant sodium ion channel causing prolonged QTc.

Indexed as

cLQTS, Congenital long QT syndromeCompound heterozygotesFDRs, First degree relativesLQT3, Long QT syndrome type-3LQTSLQTS, Long QT syndromePolymorphismsSCN5ASCN5A, Sodium channel, voltage-gated, type V, alpha subunit

Identifiers

PMID26401487
PMCPMC4561237
OpenAlexW1796787380

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.